PRISM study of a Compound NCGC01219867

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

NATIONAL INSTITUTES OF HEALTH OLAO

Contract Value

Not provided

Codes & Classification
Solicitation Number

75N98026Q00990

NAICS

541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Classification Code

Q301

Additional Details
Set Aside

None

Place of Performance

-

SourceSAM
Documents1
The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, has issued a solicitation (Procurement Identifier: 75N98026Q00990) for the PRISM study of a compound identified as NCGC01219867. This procurement seeks commercial products or services in accordance with FAR Subpart 12.6, utilizing streamlined procedures under FAR 12.603. The solicitation is being conducted as a combined synopsis/solicitation, meaning all necessary information for proposal submission is included within this notice, and no separate solicitation document will be issued. The primary objective of this procurement is to engage qualified contractors to conduct a PRISM (Profiling Relative Inhibition Simultaneously in Mixtures) study on the specified compound, NCGC01219867. The intended outcome is to generate robust research and development data that will inform further scientific and medical evaluation of this compound. The scope of work is expected to encompass all activities necessary to complete the PRISM study, adhering to the standards and requirements typical for research and development in the physical, engineering, and life sciences fields. Key requirements for this opportunity include demonstrated expertise in conducting advanced research studies within the NAICS code 541715—Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology). Offerors must be capable of delivering high-quality, reliable results within the specified timeframe and in compliance with all applicable federal regulations. The expected deliverables will likely include comprehensive study data, analysis, and reporting related to the PRISM methodology applied to compound NCGC01219867. This solicitation is unrestricted, allowing for full and open competition. There are no set-aside requirements for small businesses or other socioeconomic categories. The applicable small business size standard under NAICS 541715 is 1,000 employees. The contract will be awarded as a firm-fixed-price agreement to the offeror whose proposal represents the best value to the government. The contracting entity for this procurement is the National Institutes of Health OLAO, a federal office within the Department of Health and Human Services. The primary point of contact for this solicitation is Jaddua C. Johnston, who can be reached via email at [email protected]. Interested contractors should note that the solicitation incorporates all provisions and clauses in effect as of Federal Acquisition Circular dated August 7, 2026. The opportunity was posted on August 18, 2026, with responses due by August 24, 2026. Additional details, including any attachments, can be accessed via the official SAM.gov opportunity listing (Opportunity ID: 50253e27372c4c1f823f22b021e569e9). Contractors with proven capabilities in life sciences research and experience with PRISM studies are encouraged to review the solicitation in detail and consider submitting a proposal. This opportunity represents a significant engagement with NIH, supporting critical research initiatives with potential long-term impact in the scientific and medical communities.